This site is intended for Healthcare Professionals only.

Battle for Boots: Issa brothers vs Mukesh Ambani

Date:

Share post:

Britain’s billionaire Issa brothers and Indian tycoon Mukesh Ambani are preparing to face off in the final battle for Boots UK ownership, according to Bloomberg.

In the first round, Issa brothers have submitted the highest offer, the people with knowledge of the matter told Bloomberg.

“The brothers are going up against Ambani, who’s been working on a bid together with buyout firm Apollo Global Management Inc.”

The source said: “Bidders are now sizing up Boots’ billions in pension guarantees — which they’ll have to take on — as they figure out how much they can pay for the business.”

They’re also working around the clock to arrange financing in a difficult market, which has gotten that much tougher due to the war in Ukraine, soaring inflation and rising interest rates, according to the people.

Suitors are getting a few extra days to prepare their bids as the May 16 deadline has been further pushed to later in the week, the source told Bloomberg.

Read the full story here.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

[my_vc_php_output]

Related articles

Boots pharmacy closures in Hampton leave vulnerable residents struggling – Munira Wilson MP tells Parliament

She pointed out that a major factor driving pharmacy closures is a significant real-term reduction in pharmacy funding   Munira Wilson,...

Prof Mahendra Patel leads innovative research study: Community pharmacies to address health disparities

The research study is set to utilise community pharmacies and pharmacy technicians to recruit participants and gather crucial...

Rosehill Pharmacy gets a makeover under new leadership

Rosehill Pharmacy in Sutton has recently undergone a significant transformation with its acquisition by Arun Kanagaratnam, who took...

Drug shortage: Kay-Cee-L syrup to be out of stock from late September

Healthcare providers are advised to prioritise remaining supplies of Kay-Cee-L syrup for patients requiring doses of less than...